309 related articles for article (PubMed ID: 34920057)
1. Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review.
Laraib U; Sargazi S; Rahdar A; Khatami M; Pandey S
Int J Biol Macromol; 2022 Jan; 195():356-383. PubMed ID: 34920057
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
Bekci TT; Senol T; Maden E
J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
[TBL] [Abstract][Full Text] [Related]
3. Nanomaterial-based biosensors for detection of prostate specific antigen.
Damborska D; Bertok T; Dosekova E; Holazova A; Lorencova L; Kasak P; Tkac J
Mikrochim Acta; 2017 Jul; 184(9):3049-3067. PubMed ID: 29109592
[TBL] [Abstract][Full Text] [Related]
4. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
Yang J; Tang A; Ma J; Sun X; Ming L
Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773
[TBL] [Abstract][Full Text] [Related]
5. Clinical Evaluation of Serum Tumor Markers in the Diagnosis of Gastric Adenocarcinoma Staging and Grading.
Ghaderi B; Moghbel H; Daneshkhah N; Babahajian A; Sheikhesmaeili F
J Gastrointest Cancer; 2019 Sep; 50(3):525-529. PubMed ID: 29806060
[TBL] [Abstract][Full Text] [Related]
6. Label-free and high-throughput biosensing of multiple tumor markers on a single light-addressable photoelectrochemical sensor.
Wang J; Long J; Liu Z; Wu W; Hu C
Biosens Bioelectron; 2017 May; 91():53-59. PubMed ID: 27988479
[TBL] [Abstract][Full Text] [Related]
7. Carbon-based biosensors from graphene family to carbon dots: A viewpoint in cancer detection.
Safari M; Moghaddam A; Salehi Moghaddam A; Absalan M; Kruppke B; Ruckdäschel H; Khonakdar HA
Talanta; 2023 Jun; 258():124399. PubMed ID: 36870153
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9 and C-erb B-2, beta HCG immunohistochemistry in advanced colorectal cancer.
Webb A; Scott-Mackie P; Cunningham D; Norman A; Andreyev J; O'Brien M; Bensted J
Ann Oncol; 1995 Jul; 6(6):581-7. PubMed ID: 8573538
[TBL] [Abstract][Full Text] [Related]
9. A Review on Biosensors and Recent Development of Nanostructured Materials-Enabled Biosensors.
Naresh V; Lee N
Sensors (Basel); 2021 Feb; 21(4):. PubMed ID: 33562639
[TBL] [Abstract][Full Text] [Related]
10. Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study.
van Rossum HH; Holdenrieder S; Ballieux BEPB; Badrick TC; Yun YM; Zhang C; Patel D; Thelen M; Song J; Wojtalewicz N; Unsworth N; Vesper HW; Cui W; Ramanathan LV; Sturgeon C; Meng QH
Clin Chem; 2024 Apr; 70(4):669-679. PubMed ID: 38385453
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
Yu M; Wang YH; Abdalla AME; Liu WQ; Mei F; Wang J; Ouyang CX; Li YQ
J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):722-728. PubMed ID: 25318883
[TBL] [Abstract][Full Text] [Related]
12. Tumor marker workshops.
Rye PD; Nustad K; Stigbrand T
Tumour Biol; 2003; 24(4):165-71. PubMed ID: 14654709
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
Bozkurt M; Yumru AE; Aral I
Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantitative detection of multiple tumor markers with a rapid and sensitive multicolor quantum dots based immunochromatographic test strip.
Wang C; Hou F; Ma Y
Biosens Bioelectron; 2015 Jun; 68():156-162. PubMed ID: 25562743
[TBL] [Abstract][Full Text] [Related]
15. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites.
Zhu FL; Ling AS; Wei Q; Ma J; Lu G
Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Detection of Gastrointestinal Tumor Markers Using a Machine Learning Algorithm and Multicolor Quantum Dot Biosensor.
Saren G; Zhu L; Han Y
Comput Intell Neurosci; 2022; 2022():9022821. PubMed ID: 36093502
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer.
Webb A; Scott-Mackie P; Cunningham D; Norman A; Andreyev J; O'Brien M; Bensted J
Eur J Cancer; 1996 Jan; 32A(1):63-8. PubMed ID: 8695243
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Zhang Y; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in nanotechnology-enhanced biosensors for α-fetoprotein detection.
Liu G; Liu J; Zhou H; Wang H
Mikrochim Acta; 2022 Dec; 190(1):3. PubMed ID: 36469175
[TBL] [Abstract][Full Text] [Related]
20. Recent Progress in Biosensors for Detection of Tumor Biomarkers.
Li M; Jiang F; Xue L; Peng C; Shi Z; Zhang Z; Li J; Pan Y; Wang X; Feng C; Qiao D; Chen Z; Luo Q; Chen X
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
